• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Lysosomal Storage Diseases, Nervous System

Lysosomal Storage Diseases, Nervous System - 15 Studies Found

Completed : Cardiopulmonary Exercise Test to Quantify Enzyme Replacement Response in Pediatric Pompe Disease
: Enzyme Replacement Therapy in Pompe Disease
: 2017-04-30
Not yet recruiting : Search for Serum/Plasma Biomarkers in Pompe's Disease
:
  • Late Onset Pompe Disease
  • Pompe Disease

: 2017-01-27
: Drug: Enzyme Replacement Agent Patients will be treated following the decision of their doctors. The inv
Not yet recruiting : A Study to Assess Safety and Efficacy of NeoGAA Administered Every Other Week in Pediatric Patients With Infantile-onset Pompe Disease Previously Treated With Alglucosidase Alfa
: Glycogen Storage Disease Type II-Pompe's Disease
: 2016-12-20
:
  • Drug: GZ402666 Pharmaceutical

Recruiting : Pompe Telemedicine Developmental Study
:
  • Pompe Disease
  • Glycogen Storage Disease II

: 2016-06-22
Completed : Feasability and Interest of Screening for Infantile Pompe's Diseases at Birth
: Pompe's Disease
: 2016-09-06
: Other: observational (no intervention)
Completed : Prevalence of Heterozygote Mothers for Pompe's Disease Among Mothers Having Delivered in French Guiana
: Pompe's Disease
: 2016-09-06
: Other: observational
Not yet recruiting : VAL-1221 Delivered Intravenously in Ambulatory and Ventilator-free Patients With Late-Onset Pompe Disease
: Pompe Disease
: 2016-09-08
:
  • Drug: VAL-1221 1 mg/kg VAL-122

Completed : Investigating Pompe Prevalence in Neuromuscular Medicine Academic Practices
: Pompe Disease
: 2016-05-12
Completed : Long-term Outcome in Late-onset Pompe Disease Treated Beyond 36 Months (ATBIG-Pompe-Study)
: Pompe Disease
: 2016-06-20
: Drug: glucosidase alfa Long-term use in an observational study of licenced drug
Completed : Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
: Glycogen Storage Disease Type II-Pompe's Disease
: 2016-05-23
:
  • Drug: GZ402666

Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.